Given comparable data to a study using markers CD5/CXCR4 [8], CD5/CD19 coexpression might represent a combination of markers capable of reflecting biological differences between CLL clones, an assumption that needs to be verified in future studies. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.